COA/ICORS2019: No effect on fracture healing, improved ROM with ketotifen fumarate for reducing PTJC
Ketotifen Fumarate Does Not Impair Fracture Healing When Used for Reduction of Post-traumatic Elbow Joint Contracture
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
91 patients with elbow fractures included in the PERK clinical trial study were included in this sub-group analysis comparing fracture healing, functional outcomes and adverse events between oral ketotifen fumarate treatment and placebo. Follow up was performed at 12 and 52 weeks. Results revealed no significant differences between the ketotifen fumarate and placebo groups in fracture healing, inc...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE